Riskpilot← Back to searchSign inGet full accessNikmed AB
ABActiveOrg 5567819528Bysistorget 6General medical practice activities · NACE 8621Est. 20091-4 employees
Revenue 2024
SEK 4,1M
+7% vs 2023
EBITDA margin
31.7%
+62% vs 2023
Equity ratio
55.8%
Financial strength
Net profit 2024
SEK 839K
+109% vs 2023
| Revenue | SEK 4,1M | +7% |
| EBITDA | SEK 1,3M | +62% |
| Net profit | SEK 839K | +109% |
| Total assets | SEK 3,2M | +34% |
| Equity | SEK 1,8M | +87% |
| Employees | — | — |
Legal name
Nikmed AB
Org number
5567819528
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 maj 2009
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet ska vara att tillhandahålla sjukvårdstjänster och konsultationer inom sjukvårdsområdet samt därmed förenlig verksamhet.
Address
Bysistorget 6
Email
andersgmniklassn@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 048 | 3 377 | 3 175 | 3 868 | 4 131 |
| Staff expenses | — | — | −1 065 | −1 006 | −1 009 |
| EBITDA | 899 | 446 | 568 | 809 | 1 311 |
| Depreciation & amort. | −27 | −2 | — | — | — |
| EBIT | 872 | 444 | 568 | 809 | 1 311 |
| Net financials | −43 | −2 670 | −56 | −107 | −3 |
| Profit before tax | 629 | −1 020 | 368 | 516 | 1 075 |
| Tax | −142 | −68 | −89 | −116 | −236 |
| Net profit | 487 | −1 088 | 279 | 401 | 839 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 260 | 4 168 | 4 358 | 2 422 | 3 240 |
| Equity | 1 377 | 289 | 568 | 969 | 1 808 |
| Long-term debt | 675 | 2 052 | 1 666 | 0 | — |
| Short-term debt | 587 | 1 098 | 1 249 | 394 | 140 |
| Total debt | 1 262 | 3 150 | 2 916 | 394 | 140 |
EBITDA margin
31.7%
This company
15.8%
Market median
+101% vs market
20202024
Equity ratio
55.8%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
46.4%
This company
18.4%
Market median
+152% vs market
20202024
Net profit margin
20.3%
This company
8.1%
Market median
+151% vs market
20202024
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nikmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Magnus Holmgren | Audit | 0 companies |
| Anders Georg Mattias Niklasson | Board of Directors | 0 companies |
| Nils Holger Mattias Niklasson | Deputy Board Member | 0 companies |